TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone

In this video first shown on theheart.org | Medscape Cardiology, Mayo Clinic cardiologists Martha Grogan, M.D., and Omar F. Abou Ezzeddine, M.D., discuss transthyretin (TTR) amyloidosis and AL amyloidosis.
General characteristics of cardiac amyloidosis can include unexplained heart failure, unexplained atrial fibrillation, and physical exam findings such as jugular venous pressure elevation, lower extremity edema, abdominal distension and many more. Diagnosis and treatment of amyloidosis vary depending on the type. Patients with amyloidosis can deteriorate rapidly, so diagnosing quickly is very important.
For more information on the diagnosis and treatment of amyloidosis or to request an appointment, visit mayocl.in/2LW72pQ